Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation
Clinical trial NCT00468767 · COMPLETED
Trial details
- NCT number
- NCT00468767
- Sponsor
- Advanz Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2004-11-01
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.